Basso Industry Corp. logo

Basso Industry Corp. (1527)

Market Closed
12 Jun, 05:30
TWSE TWSE
NT$
33. 25
+0.1
+0.3017%
NT$
4.91B Market Cap
16.83 P/E Ratio
8.8% Div Yield
147,104 Volume
18.19 Eps
NT$ 33.15
Previous Close
Add Transaction
Day Range
33.2 33.6
Year Range
31.15 39.4
Want to track 1527 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1527 closed Friday higher at NT$33.25, an increase of 0.3017% from Thursday's close, completing a monthly increase of 2.7821% or NT$0.9. Over the past 12 months, 1527 stock gained 2.3077%.
1527 pays dividends to its shareholders, with the most recent payment made on Aug 29, 2025. The next estimated payment will be in In 2 months on Aug 29, 2026 for a total of NT$2.2.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Basso Industry Corp. has completed 6 stock splits, with the recent split occurring on Oct 28, 2015.
The company's stock is traded on one exchange.

1527 Chart

People also search for

Ch Biotech R&D Co. Ltd.
NT$ 90.5
+0.8919%
United Orthopedic Corporation
NT$ 89.8
-0.333%
Adimmune Corp
NT$ 17.7
+0.2833%
TaiGen Biopharmaceuticals Holdings Limited
NT$ 8.85
+0.1131%
Huxen Corp
NT$ 44.35
+0.681%

Basso Industry Corp. (1527) FAQ

What is the stock price today?

The current price is NT$33.25.

On which exchange is it traded?

Basso Industry Corp. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 1527.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 8.8%.

What is its market cap?

As of today, the market cap is 4.91B.

Has Basso Industry Corp. ever had a stock split?

Basso Industry Corp. had 6 splits and the recent split was on Oct 28, 2015.

Basso Industry Corp. Profile

Life Sciences Tools & Services Industry
Healthcare Sector
Mr. Lin Chi-Wen CEO
TWSE Exchange
TW0001527000 ISIN
TW Country
674 Employees
4 Aug 2025 Last Dividend
13 Sep 2006 Last Split
- IPO Date

Overview

Lotus Pharmaceutical Co., Ltd., founded in 1966 and based in Taipei City, Taiwan, operates at the forefront of the pharmaceutical industry, focusing on the research, development, manufacture, and international sales of generic pharmaceutical products. With a market presence in Taiwan, South Korea, the United States, and other countries globally, Lotus Pharmaceutical is dedicated to addressing the needs of patients across a wide range of therapeutic areas. The company's business activities extend beyond pharmaceutical manufacturing to include retail of clinical machinery, biotech consulting services, and healthcare consultancy, thereby offering a comprehensive suite of solutions in the healthcare sector. Lotus Pharmaceutical has established a strategic partnership with NRX Pharmaceuticals, underlining its commitment to innovation and excellence in healthcare solutions.

Products and Services

  • Generic Pharmaceuticals:

    The core of Lotus Pharmaceutical's product line includes generic drugs concentrating on several critical therapeutic areas such as oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. Leveraging extensive research and development capabilities, the company offers high-quality, accessible medication options to patients worldwide.

  • Over-the-Counter Products:

    Beyond prescription medications, Lotus Pharmaceutical provides a variety of over-the-counter (OTC) healthcare products, catering to the daily health and wellness needs of consumers. These products offer convenient and immediate relief from common health issues, enhancing the well-being of individuals and families.

  • Retail of Clinical Machines:

    In response to the technical needs of healthcare providers, Lotus Pharmaceutical engages in the retail of clinical machines. This service not only supports medical professionals in delivering effective treatments but also ensures patients have access to the latest healthcare technologies.

  • Biotech Technological Consulting Services:

    Lotus Pharmaceutical extends its expertise through biotech technological consulting services, assisting other organizations in navigating the complex landscape of biotechnology. This includes strategy development, technological innovation, and operational guidance, fostering growth and advancement in the biotech sector.

  • Healthcare and Management Consultancy Services:

    The company offers a range of consultancy services aimed at improving health management and technology practices. This encompasses health technology, trading information services, management consultancy, pharmaceutical regulatory affairs, and project management. Lotus Pharmaceutical's consultancy services are tailored to meet the diverse needs of the healthcare industry, ensuring clients can deliver superior care and services.

  • Contract Research Organization:

    As a contract research organization (CRO), Lotus Pharmaceutical fulfills the research and development needs of the pharmaceutical and biotech industries. This service includes data collection, regulatory affairs management, and comprehensive project management for clinical trials, facilitating the development of innovative medical treatments and therapies.

Contact Information

Address: Taichung Industrial Park, Taichung, Taiwan, 40768
Phone: 886 4 2359 8877